Literature DB >> 1726322

Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release.

P F Mannaioni1, E Masini, A Pistelli, D Salvemini, J R Vane.   

Abstract

Rat serosal mast cells (MCs, 85-90% pure), obtained from peritoneal washing of Wistar albino rats, produced a significant amount of superoxide anions (O2.-) as measured by the increase in absorbance due to the reduction of ferricytochrome c; they were also able to generate a nitric oxide (NO)-like factor, as measured by two bioassay systems: i) inhibition of platelet aggregation and ii) stimulation of MCs guanylate cyclase. Incubation of MCs with human washed platelets resulted in an inhibition of thrombin-induced platelet aggregation which was proportional to cell number. The inhibitory activity of MCs was potentiated by substances which preserve NO (superoxide dismutase, SOD), and reversed by compounds which inactivate NO (oxyhaemoglobin, oxyHb) or which inhibit its synthesis (NG-monomethyl-L-arginine, MeArg). Mechanical stimulation of MCs produced a time-dependent increase in the levels of their cGMP but not cAMP; this increase was enhanced by E. coli lipopolysaccharide (LPS). NO generators such as sodium nitroprusside (NaNp) also augmented the levels of cGMP in MCs. NaNp inhibited in a dose-dependent manner the release of histamine evoked by compound 48/80 (0.5 microgram/ml), but not by the O2.--generating system (xanthine-xanthine oxidase), suggesting a bidirectional regulation of histamine release afforded by O2.- and NO.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726322

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  13 in total

Review 1.  Nitric oxide and the gut.

Authors:  D Jourd'heuil; M B Grisham; D N Granger
Journal:  Curr Gastroenterol Rep       Date:  1999-10

2.  21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties.

Authors:  M Paul-Clark; P Del Soldato; S Fiorucci; R J Flower; M Perretti
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Localization of nitric oxide synthase immunoreactivity in mast cells of human nasal mucosa.

Authors:  S Bacci; R Arbi-Riccardi; B Mayer; C Rumio; M B Borghi-Cirri
Journal:  Histochemistry       Date:  1994-08

4.  NOD1 and NOD2 Interact with the Phagosome Cargo in Mast Cells: A Detailed Morphological Evidence.

Authors:  Giuliano Zabucchi; Elisa Trevisan; Francesca Vita; Maria Rosa Soranzo; Violetta Borelli
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

5.  Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition.

Authors:  A C Brooks; C J Whelan; W M Purcell
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 6.  Role of nitroso radicals as drug targets in circulatory shock.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

7.  Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo.

Authors:  Emanuela Masini; Salvatore Cuzzocrea; Emanuela Mazzon; Cosimo Marzocca; Pier Francesco Mannaioni; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

Review 8.  Role of nitric oxide in mast cells: controversies, current knowledge, and future applications.

Authors:  Yokananth Sekar; Tae Chul Moon; Samira Muñoz; A Dean Befus
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  Ketotifen ameliorates capsaicin-augmented acetic acid-induced colitis.

Authors:  R Eliakim; F Karmeli; E Okon; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

10.  Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs.

Authors:  E Masini; D Bani; M Bigazzi; P F Mannaioni; T Bani-Sacchi
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.